Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/31228053/ below:

Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients

Affiliations

• ¹ Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, School of Public Health, 6011 Harry Hines Blvd. V8.112, Dallas, TX, 75390, USA. Katelyn.k.jetelina@uth.tmc.edu.
• ² Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, School of Public Health, 6011 Harry Hines Blvd. V8.112, Dallas, TX, 75390, USA.
• ³ Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ⁴ Moncrief Cancer Center, Fort Worth, TX, USA.
• ⁵ Rady School of Management, University of California, San Diego, San Diego, CA, USA.
• ⁶ Department of Internal Medicine, University of California, San Diego, San Diego, CA, USA.

• PMID: 31228053
• PMCID: PMC6712145
• DOI: 10.1007/s11606-019-05117-0

Item in Clipboard

Katelyn K Jetelina et al. J Gen Intern Med. 2019 Sep.

• ¹ Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, School of Public Health, 6011 Harry Hines Blvd. V8.112, Dallas, TX, 75390, USA. Katelyn.k.jetelina@uth.tmc.edu.
• ² Department of Epidemiology, Human Genetics, and Environmental Sciences, University of Texas Health Science Center, School of Public Health, 6011 Harry Hines Blvd. V8.112, Dallas, TX, 75390, USA.
• ³ Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ⁴ Moncrief Cancer Center, Fort Worth, TX, USA.
• ⁵ Rady School of Management, University of California, San Diego, San Diego, CA, USA.
• ⁶ Department of Internal Medicine, University of California, San Diego, San Diego, CA, USA.

• PMID: 31228053
• PMCID: PMC6712145
• DOI: 10.1007/s11606-019-05117-0

Item in Clipboard

Background: For colorectal cancer (CRC) screening to improve survival, patients with an abnormal fecal immunochemical test (FIT) must follow-up with a diagnostic colonoscopy. Adherence to follow-up is low and patient-level barriers for suboptimal adherence have yet to be explored.

Objective: To characterize barriers for non-completion of diagnostic colonoscopy after an abnormal FIT reported by under- and uninsured patients receiving care in a safety-net health system.

Design: A longitudinal, cohort study of CRC screening outreach to 8565 patients using mailed FIT kits. Patients with abnormal FIT results received telephonic navigation to arrange for a no-cost diagnostic colonoscopy.

Patients: Adults aged 50-64 years receiving care at a North Texas safety-net health system.

Approach: Descriptive analyses characterized the patient sample and reasons for lack of follow-up after abnormal FIT over the 3-year outreach program. Thematic qualitative analyses characterized reasons for lack of follow-up with a colonoscopy after the abnormal FIT.

Key results: Of 689 patients with an abnormal FIT, 45% (n = 314) did not complete a follow-up colonoscopy. Among the 314 non-completers, 184 patients reported reasons for not completing a follow-up colonoscopy included health insurance-related challenges (38%), comorbid conditions (37%), social barriers such as transportation difficulties and lack of social support (29%), concerns about FIT/colonoscopy process (12%), competing life priorities (12%), adverse effects of bowel preparation (3%), and poor health literacy (3%). Among the 314 non-completers, 131 patients did not report a barrier, as 51% reported that that had completed a previous colonoscopy in the past 10 years, 10% refused with no reason, and 10% were never reached by phone.

Conclusions: Future studies aimed at improving FIT screening and subsequent colonoscopy rates need to address the unique needs of patients for effective and sustainable screening programs.

Trial registration: NCT01946282.

Keywords: colorectal cancer; diagnostic colonoscopy; fecal immunochemical test; safety-net; screening.

PubMed Disclaimer

The authors declare that they do not have a conflict of interest.

CONSORT diagram.

CONSORT diagram.

CONSORT diagram.

Non-mutually exclusive patient-reported barriers to…

Non-mutually exclusive patient-reported barriers to failure for diagnostic colonoscopy following abnormal FIT (…

Non-mutually exclusive patient-reported barriers to failure for diagnostic colonoscopy following abnormal FIT ( n = 184).

• Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

  Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, Mayorga CA, Murphy C, Tiro JA, McCallister K, Sanders JM, Bishop WP, Loewen AC, Halm EA. Singal AG, et al. JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389. JAMA. 2017. PMID: 28873161 Free PMC article. Clinical Trial.

• Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

  Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, Valdez L, Tong L, Ahn C, Kashner M, Argenbright K, Tiro J, Geng Z, Pruitt S, Skinner CS. Gupta S, et al. JAMA Intern Med. 2013 Oct 14;173(18):1725-32. doi: 10.1001/jamainternmed.2013.9294. JAMA Intern Med. 2013. PMID: 23921906 Free PMC article. Clinical Trial.

• Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.

  Martin J, Halm EA, Tiro JA, Merchant Z, Balasubramanian BA, McCallister K, Sanders JM, Ahn C, Bishop WP, Singal AG. Martin J, et al. Am J Med. 2017 Jan;130(1):93.e1-93.e7. doi: 10.1016/j.amjmed.2016.07.028. Epub 2016 Aug 31. Am J Med. 2017. PMID: 27591183 Free PMC article.

• Developing Patient-Refined Messaging for Follow-Up Colonoscopy After Abnormal Fecal Testing in Hispanic Communities: Key Learnings from Virtual Boot Camp Translation.

  Thompson JH, Rivelli JS, Escaron AL, Garcia J, Ruiz E, Torres-Ozadali E, Gautom P, Richardson DM, Thibault A, Coronado GD. Thompson JH, et al. Hisp Health Care Int. 2024 Dec;22(4):216-224. doi: 10.1177/15404153231212659. Epub 2023 Nov 7. Hisp Health Care Int. 2024. PMID: 37936370 Review.

• Patient barriers and facilitators of colonoscopy use: A rapid systematic review and thematic synthesis of the qualitative literature.

  Kerrison RS, Sheik-Mohamud D, McBride E, Whitaker KL, Rees C, Duffy S, von Wagner C. Kerrison RS, et al. Prev Med. 2021 Apr;145:106413. doi: 10.1016/j.ypmed.2020.106413. Epub 2021 Jan 4. Prev Med. 2021. PMID: 33412167 Review.

• Triage May Improve Selection to Colonoscopy and Reduce the Number of Unnecessary Colonoscopies.

  Petersen MM, Ferm L, Kleif J, Piper TB, Rømer E, Christensen IJ, Nielsen HJ. Petersen MM, et al. Cancers (Basel). 2020 Sep 12;12(9):2610. doi: 10.3390/cancers12092610. Cancers (Basel). 2020. PMID: 32932734 Free PMC article.

• Colorectal Cancer Screening Prevalence, Perceived Barriers, and Preference for Screening Colonoscopy Among Hospitalized Women.

  Graham H, Kauffman R, Khaliq W. Graham H, et al. Turk J Gastroenterol. 2022 Nov;33(11):901-908. doi: 10.5152/tjg.2022.21567. Turk J Gastroenterol. 2022. PMID: 35946889 Free PMC article.

• How spatial accessibility to colonoscopy affects diagnostic adherences and adverse intestinal outcomes among the patients with positive preliminary screening findings.

  Chen W, Zhang W, Liu H, Liang Y, Zhou Q, Li Y, Gu J. Chen W, et al. Cancer Med. 2020 Jun;9(12):4405-4419. doi: 10.1002/cam4.3054. Epub 2020 Apr 21. Cancer Med. 2020. PMID: 32319229 Free PMC article.

• Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.

  Callison K, Pesko MF, Phillips S, Sosa JA. Callison K, et al. N Engl J Med. 2023 Mar 2;388(9):824-832. doi: 10.1056/NEJMsa2209197. N Engl J Med. 2023. PMID: 36856618 Free PMC article.

• Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.

  Petrik AF, Keast E, Johnson ES, Smith DH, Coronado GD. Petrik AF, et al. BMC Health Serv Res. 2020 Nov 10;20(1):1028. doi: 10.1186/s12913-020-05883-2. BMC Health Serv Res. 2020. PMID: 33172444 Free PMC article.

1. 1. Howlader NNA, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/, Accessed February 19, 2019.
2. 1. U.S. Preventive Services Task Force. Final Recommendation Statement: Colorectal Cancer: Screening. Washington, DC; 2013.
3. 1. McLachlan S-A, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context—A systematic review of the literature. Patient Educ Couns. 2012;86(2):137–146. doi: 10.1016/j.pec.2011.04.010. - DOI - PubMed
4. 1. Sultan S, Partin MR, Shah P, et al. Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study. Patient Prefer Adherence. 2017;11:985–994. doi: 10.2147/PPA.S127862. - DOI - PMC - PubMed
5. 1. Selby K, Baumgartner C, Levin TR, et al. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017;167(8):565–575. doi: 10.7326/M17-1361. - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3